At the news
? BULLISHIMPACT 7/10 425 filed Jul 20, 2026 at 09:05 ET
Tempus AI (TEM) announced a definitive agreement to acquire Personalis (PSNL) for $16.25/share in a stock-for-stock transaction valued at $1.5B enterprise value (net of Tempus's existing stake). The deal brings Personalis's industry-leading MRD technology into Tempus's AI-enabled precision oncology platform, expanding into a $20B market opportunity. Closing is expected in late 2026/early 2027, subject to Personalis shareholder and regulatory approvals.
- Consideration of $16.25 per share, 6% premium to Friday's close and 28% premium to 30-day VWAP
- Total enterprise value of $1.5 billion, net of Tempus's existing ownership interest
- 100% stock transaction; Tempus may elect cash up to 50% of consideration, financed with cash on hand and credit facilities
- Floating exchange ratio capped at 0.3356 shares of TEM per PSNL share
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access